Biotech · Private company · Chicago, IL, US
Schedule 1 Therapeutics, Inc.
Track this companyFree. Adds Schedule 1 Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Optimization of Cannabinoids for Development as FDA-Approved Migraine TherapeuticsFiscal year 2025 · $864.4KNIH RePORTER 5R44DA051309-03 · fetched Nov 12, 2026
- Optimization of Cannabinoids for Development as FDA-Approved Migraine TherapeuticsFiscal year 2024 · $2MNIH RePORTER 2R44DA051309-02A1 · fetched Nov 12, 2026